Drug
Chenodeoxycholic Acid clinical trials
Also written CDCA.
- studies test it
- 11
- open now
- 0
- in phase 3
- 1
- first study started
- 1996
How studies write it
Studies that test it under each name
Name
Other names
- CDCA
- 2
Studies by the year they started
11 studies that test it; most in 1996 (1)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1999 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 1
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 9
Hvidovre University Hospital (2) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Humanis Saglık Anonim Sirketi (1) · Zealand University Hospital (1) · University Hospital, Gentofte, Copenhagen (1) · Mayo Clinic (1) · University Hospital, Basel, Switzerland (1) · National Center for Research Resources (NCRR) (1)
Often tested with
Tested in the same studies.
Colesevelam (2) · Resveratrol (1) · Atorvastatin (1) · Ursodeoxycholic Acid (1) · Lovastatin (1)
Studies
Open first, then newest update. How each study uses Chenodeoxycholic Acid is read from its arms, and is right about nine times in ten.
Testing it · 11
- Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5CompletedPhase 2Institut National de la Santé Et de la Recherche Médicale, FranceNCT02314208Written as Xenbilox
- A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)WithdrawnPhase 3Leadiant Biosciences, Inc.NCT06260748Written as Chenodeoxycholic acid
- Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)CompletedPhase 1Humanis Saglık Anonim SirketiNCT06180057Written as Chenodeoxycholic acid
- Changes in Bile Acid Homeostasis and Stool Habits After CholecystectomyCompletedPhase 4Zealand University HospitalNCT03168555Written as chenodeoxycholic acid
- Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02876484Written as Chenodeoxycholic Acid
- Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02340247Written as Chenodeoxycholic Acid
- Effect of Bile Acids on GLP-1 SecretionCompletedNot applicableUniversity Hospital, Gentofte, CopenhagenNCT01666223Written as Chenodeoxycholic Acid
- Cholestanol in HumansWithdrawnNot applicableUS Department of Veterans AffairsNCT00018694Written as Chenodeoxycholic Acid
- Cheno Effect on Transit in Health and IBS-CCompletedPhase 2Mayo ClinicNCT00912301Written as Sodium chenodeoxycholate (NaCDC)
- Effects of FXR Activation on Hepatic Lipid and Glucose MetabolismCompletedEarly Phase 1University Hospital, Basel, SwitzerlandNCT00465751Written as chenodeoxycholic acid
- Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous XanthomatosisStatus unknownPhase 2National Center for Research Resources (NCRR)NCT00004346Written as chenodeoxycholic acid
Given in every arm · 1 — Chenodeoxycholic Acid is usual care beside what is tested
Codes
What other systems call Chenodeoxycholic Acid · ClinicalTrials.gg INT007187
- MeSH (NLM) D002635Chenodeoxycholic AcidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0GEI24LG0JCHENODIOLConfirmed FDA, NLM
- RxNorm 2323One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002635 | Chenodeoxycholic Acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0GEI24LG0J | CHENODIOL | Confirmed FDA, NLM |
| RxNorm | 2323 | — | One source FDA |
Also registered as sodium chenodeoxycholate (UNII 6V4571KSKE).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.